Cryospray Improved COPD Symptoms
Clinical trial results showed CSA Medical's Metered CryoSpray procedure significantly eases chronic lung symptoms and lowers severe hospital events.
Tag: Rejuvenair cryospray
All
Latest
Cryospray Improved COPD Symptoms
Clinical trial results showed CSA Medical’s Metered CryoSpray procedure significantly eases chronic lung symptoms and lowers severe hospital events.
Read More
Cryospray Improved Chronic Bronchitis Symptoms
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Read More
Metered Cryospray Therapy Linked to Airway Remodeling in Chronic Bronchitis
Data shows that metered cryospray therapy with the investigational RejuvenAir System leads to airway remodeling and improved symptoms in chronic bronchitis patients.
Read More
Early Data Promising for Cryospray COPD Treatment
A 12-month feasibility study of the RejuvenAir Metered Cryospray system revealed “clinically meaningful improvements” in COPD patients with chronic bronchitis.
Read More
Funding to Advance Cryosprays for Lung, GI Diseases
CSA Medical Inc has secured $23 million in financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair.
Read More
First Chronic Bronchitis Patients Treated with RejuvenAir ‘Cryospray’
A clinical study will evaluate the safety and feasibility of treating chronic bronchitis patients with the RejuvenAir System, a “cryotherapy” spray that freezes and ablates unwanted tissue inside the lungs.
Read More